Advertisement
Screener

Takeda Pharmaceutical Company Limited (TKPHF) Form 13F-HR: Institutional investment manager holdings report

Takeda Pharmaceutical Company Limited Form 13F-HR: Institutional investment manager holdings report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-11-13: Form 13F-HR; Period of report 2025-09-30; Description Institutional investment manager holdings report; Document xslForm13F_X02/primary_doc.xml.
  • 2025-08-08: Form 13F-HR; Period of report 2025-06-30; Description Institutional investment manager holdings report; Document xslForm13F_X02/primary_doc.xml.
  • 2025-05-12: Form 13F-HR; Period of report 2025-03-31; Description Institutional investment manager holdings report; Document xslForm13F_X02/primary_doc.xml.
  • 2025-02-13: Form 13F-HR; Period of report 2024-09-30; Description Institutional investment manager holdings report; Document xslForm13F_X02/primary_doc.xml.
FiledFormPeriod of reportDescriptionDocument
2025-11-1313F-HR2025-09-30Institutional investment manager holdings reportxslForm13F_X02/primary_doc.xml
2025-08-0813F-HR2025-06-30Institutional investment manager holdings reportxslForm13F_X02/primary_doc.xml
2025-05-1213F-HR2025-03-31Institutional investment manager holdings reportxslForm13F_X02/primary_doc.xml
2025-02-1313F-HR2024-09-30Institutional investment manager holdings reportxslForm13F_X02/primary_doc.xml
2025-02-1313F-HR2024-06-30Institutional investment manager holdings reportxslForm13F_X02/primary_doc.xml
2025-02-1313F-HR2024-03-31Institutional investment manager holdings reportxslForm13F_X02/primary_doc.xml
2025-02-1313F-HR2023-12-31Institutional investment manager holdings reportxslForm13F_X02/primary_doc.xml
2025-02-1213F-HR2024-12-31Institutional investment manager holdings reportxslForm13F_X02/primary_doc.xml